Combination Therapy For Preventing Or Treating Obesity

Abstract: The present invention relates to a combination therapy for effectively preventing or treating obesity. More specifically, the objective of the present invention is to effectively prevent or treat obesity through a synergistic effect obtained when a melanocortin-4 receptor (MC4R) agonist and a glucagon-like peptide-1 (GLP-1) receptor agonist are administered in combination.

Patent Information

Application #

Filing Date

28 October 2024

Publication Number

51/2024

Publication Type

INA

Invention Field

CHEMICAL

Status

Email

Parent Application

Applicants

LG CHEM, LTD.

128, Yeoui-daero Yeongdeungpo-gu Seoul 07336

Inventors

1. PARK, Hee Dong

E8 Block LG Science Park, 30, Magokjungang 10-ro Gangseo-gu Seoul 07796

2. YEO, Su Jin

E8 Block LG Science Park, 30, Magokjungang 10-ro Gangseo-gu Seoul 07796

3. HWANG, Hye Kyeong

E8 Block LG Science Park, 30, Magokjungang 10-ro Gangseo-gu Seoul 07796

Specification

Documents

Application Documents

#	Name	Date
1	202417082085-STATEMENT OF UNDERTAKING (FORM 3) [28-10-2024(online)].pdf	2024-10-28
2	202417082085-REQUEST FOR EXAMINATION (FORM-18) [28-10-2024(online)].pdf	2024-10-28
3	202417082085-POWER OF AUTHORITY [28-10-2024(online)].pdf	2024-10-28
4	202417082085-FORM 18 [28-10-2024(online)].pdf	2024-10-28
5	202417082085-FORM 1 [28-10-2024(online)].pdf	2024-10-28
6	202417082085-DRAWINGS [28-10-2024(online)].pdf	2024-10-28
7	202417082085-DECLARATION OF INVENTORSHIP (FORM 5) [28-10-2024(online)].pdf	2024-10-28
8	202417082085-COMPLETE SPECIFICATION [28-10-2024(online)].pdf	2024-10-28
9	202417082085-Verified English translation [04-11-2024(online)].pdf	2024-11-04
10	202417082085-Response to office action [04-11-2024(online)].pdf	2024-11-04
11	202417082085-FORM 3 [23-12-2024(online)].pdf	2024-12-23
12	202417082085-Proof of Right [03-03-2025(online)].pdf	2025-03-03